BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
9.09
-0.04 (-0.44%)
Mar 13, 2026, 4:00 PM EDT - Market closed
BBOT Market Cap
BBOT has a market cap or net worth of $727.5 million as of March 13, 2026. Its market cap has increased by 189.21% in one year.
Market Cap
727.50M
Enterprise Value
304.80M
1-Year Change
189.21%
Ranking
Category
Stock Price
$9.09
Market Cap Chart
Since February 9, 2024, BBOT's market cap has increased from $38.21M to $727.50M, an increase of 1,803.82%. That is a compound annual growth rate of 310.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 730.70M | -27.04% |
| Dec 31, 2025 | 1.00B | 305.70% |
| Dec 31, 2024 | 246.84M | 545.98% |
| Feb 9, 2024 | 38.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kura Oncology | 780.84M |
| Ocugen | 767.28M |
| Lexicon Pharmaceuticals | 728.73M |
| Tenax Therapeutics | 713.76M |
| Gyre Therapeutics | 709.40M |
| Theravance Biopharma | 703.84M |
| Bright Minds Biosciences | 702.88M |
| Alto Neuroscience | 690.60M |